Cargando…

Influence of polidocanol ultrasound-guided foam sclerotherapy on quality of life in lower extremity chronic venous disease: initial results

Chronic Venous Insufficiency (CVI) is not only detrimental to patients’ Quality of Life (QoL) but also places a considerable burden on public health resources. Ultrasound guided foam sclerotherapy (USFS) is a good treatment option, but its effect on patients’ QOL is still unclear. This article prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polimanti, Afonso César, Pereira, Lucas Abdo, Carmine, Tainan Montecorado, Fürst, Rafael Vilhena de Carvalho, Bezerra, Alexandre Sacchetti, Corrêa, João Antônio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2019
Materias:	Innovations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805124/ https://www.ncbi.nlm.nih.gov/pubmed/31673252 http://dx.doi.org/10.1590/1677-5449.190049

Ejemplares similares

Digital Subtraction Angiography-Guided Foam Sclerotherapy with Polidocanol for Treating Superficial Venous Malformation
por: Anh, Tuan Tran, et al.
Publicado: (2021)

Sclerotherapy using polidocanol foam for a giant splenic cyst
por: Funakoshi, Hiraku, et al.
Publicado: (2020)

Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue
por: Mukul, Sailesh Kumar, et al.
Publicado: (2019)

Bilateral foam polidocanol sclerotherapy of great saphenous veins and their tributaries in synchronous procedure
por: Miranda, Luiz Antonio, et al.
Publicado: (2021)

Algorithm for diagnosis of primary vasculitides
por: Bezerra, Alexandre Sacchetti, et al.
Publicado: (2019)

Sclerotherapy with polidocanol microfoam in head and neck venous and lymphatic malformations
por: De Corso, Eugenio, et al.
Publicado: (2021)

Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease
por: Gallo, Gaetano, et al.
Publicado: (2021)

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018)

Propranolol Followed by a Foam Sclerotherapy for Treatment of Tufted Angioma over Neck: A Novel Therapeutic Approach
por: Zawar, Vijay, et al.
Publicado: (2020)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)

Influence of intraoperative findings on immediate flow through radial-cephalic arteriovenous wrist fistulas for hemodialysis access
por: Polimanti, Afonso César, et al.
Publicado: (2018)

Therapeutic Effect of Polidocanol Sclerotherapy on Oral Vascular Malformations
por: Fukuzawa, Satoshi, et al.
Publicado: (2021)

Early diagnosis and treatment of Leukocytoclastic Vasculitis: case report
por: Bezerra, Alexandre Sacchetti, et al.
Publicado: (2020)

Ultrasound-guided foam sclerotherapy of great saphenous vein with 2% polidocanol – one-year follow-up results
por: Kurnicki, Jacek, et al.
Publicado: (2016)

Effect of Hyaluronic Acid and Pluronic-F68 on the Surface Properties of Foam as a Delivery System for Polidocanol in Sclerotherapy
por: del Castillo-Santaella, Teresa, et al.
Publicado: (2020)

Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study
por: Salgueiro, P., et al.
Publicado: (2022)

Familial Disseminated Cutaneous Glomuvenous Malformation: Treatment with Polidocanol Sclerotherapy
por: Jha, Aditi, et al.
Publicado: (2016)

Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma
por: Aoyama, Taiki, et al.
Publicado: (2020)

Polidocanol sclerotherapy for multiple gastrointestinal hemangiomas: A case report
por: Yao, Huan, et al.
Publicado: (2021)

Successful Treatment of Acquired Vulvar Lymphangiectasia with 1% Polidocanol Sclerotherapy
por: STULL, Carolyn M., et al.
Publicado: (2021)

3% Polidocanol Sclerotherapy for Pyogenic Granuloma: Efficacy and Safety Analysis
por: Deshpande, Ajay J, et al.
Publicado: (2022)

Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as “bridge treatment” during the COVID-19 pandemic in Italy
por: Lisi, Giorgio, et al.
Publicado: (2021)

Livedoid Vasculopathy: diagnosis and treatment in pregnant women
por: Bezerra, Alexandre Sacchetti, et al.
Publicado: (2020)

Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
por: Pata, Francesco, et al.
Publicado: (2021)

Transcervical administration of polidocanol foam prevents pregnancy in female baboons()()
por: Jensen, Jeffrey T., et al.
Publicado: (2016)

Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts: Good results in 37 of 38 consecutive patients
por: Brosjö, Otte, et al.
Publicado: (2013)

Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations
por: Kitagawa, Akira, et al.
Publicado: (2018)

Handwashing With a Water-Efficient Tap and Low-Cost Foaming Soap: The Povu Poa “Cool Foam” System in Kenya
por: Whinnery, Jaynie, et al.
Publicado: (2016)

A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)
por: Gallo, G., et al.
Publicado: (2022)

Efficacy and Safety of Ultrasound-Guided Percutaneous Polidocanol Sclerotherapy in Benign Cystic Thyroid Nodules: Preliminary Results
por: Gong, Xiaohua, et al.
Publicado: (2017)

A Rare Case of Aneurysmal Bone Cyst – Navicular Bone Treated by Intralesional Sclerotherapy Agent Polidocanol
por: Bansal, Kapil, et al.
Publicado: (2021)

Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams
por: Carugo, Dario, et al.
Publicado: (2015)

Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children – A retrospective cohort study from a single tertiary medical center
por: Hou, Fang, et al.
Publicado: (2020)

Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy
por: Bai, Taoping, et al.
Publicado: (2018)

Comparison between the use of 99% ethanol and 3% polidocanol in percutaneous echoguided sclerotherapy treatment of simple renal cysts
por: Dell’Atti, Lucio
Publicado: (2015)

Effectiveness of Polidocanol in the Treatment of Venous Malformations: A Meta-Analysis
por: Hu, Wei, et al.
Publicado: (2022)

A single-center, single-arm, prospective, open-label trial to evaluate the efficacy and safety of percutaneous sclerotherapy with polidocanol for painful venous malformations (SCIRO-2001): study protocol
por: Uka, Mayu, et al.
Publicado: (2022)

Comparison of Foam and Liquid Sclerotherapy for the Treatment of Lower Extremity Varicose Veins and Telangiectasia in Obese Patients
por: Kanber, Eyüp Murat
Publicado: (2023)

Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial
por: Bertanha, Matheus, et al.
Publicado: (2014)

Polidocanol monotherapy for a superficial orbital venous malformation in a horse
por: Stonex, Tara M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k075q6jqs02eveh3gu6p4bsrta